Australian Psychiatrist Patrick McGorry Wants His Pre-Drugging Agenda to Go Global
“Australia is a place that can actually change the world in mental health, provided we get the right government support to do so.” — Patrick McGorry
“Australia is a place that can actually change the world in mental health, provided we get the right government support to do so.” — Patrick McGorry
As psychiatrists from around the world flood the area this weekend to take part in the Annual Meeting of the American Psychiatric Association (APA), psychiatric watchdog Citizens Commission on Human Rights (CCHR) is demanding that the APA sever all ties to pharmaceutical company interests and that psychiatrists stop killing children with harmful drugs.
Children as young as two are being given powerful antipsychotic medications, raising concerns use of the drugs are not being properly monitored and could be putting children at risk of serious side effects. Figures from the Commonwealth Department of Health and Ageing show 559 WA children were given at least one antipsychotic drug subsidised on the Pharmaceutical Benefits Scheme in 2007-08.
Who is Patrick McGorry and what does he promote? He’s a psychiatrist just named Australian of the Year for his work in “youth mental health reform.” What does that reform consist of? What he calls a “new form of climate change.” It sure is. He not only promotes youths being put on antipsychotics and antidepressants, cited by international drug regulatory agencies as causing hallucinations, hostility, personality change, life-threatening diabetes, strokes, suicide and death, McGorry goes a giant step further—drug them before they’ve even developed a “psychiatric” disorder. The Association for the Accreditation of Human Research Protection Programs (AHRPP) likens such concepts to “performing mastectomies on women who are at risk of—but do not have—breast cancer.”
An ongoing U.S. Senate investigation headed by Senator Charles Grassly has sought disclosure of pharmaceutical funding paid to researchers, physicians, medical schools, medical journals and the patient advocacy community. Some of the nation’s most prominent psychiatrists have now been exposed for extensive conflicts of interest amounting to millions in undisclosed pharmaceutical funding, including Dr. Charles Nemeroff, Dr. Joseph Biederman, Dr. Melissa DelBello, Dr. Timothy Wilens, Dr. Thomas Spencer, Dr. Alan Schatzberg, Dr. Martin Keller, Dr. A. John Rush, Dr. Karen Wagner, Dr. Jeffrey Bostic and Dr. Frederick Goodwin — many of which serve as advisory board members to mental illness “advocacy groups” which are now also the subject of the Senate investigation for their undisclosed pharmaceutical funding.
The majority of the public may or may not be familiar with these so-called mental health advocacy organizations, such as the National Alliance on Mental Illness (NAMI), Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD) or the myriad of bipolar, depression or ADHD “support groups” that are inundating the internet. But they need to be.